Grantee in the News: Matt Kaeberlein explores how funding aging research today will produce massive health benefits and economic gains for all in The Hill
![Grantee in the News: Matt Kaeberlein explores how funding aging research today will produce massive health benefits and economic gains for all in The Hill]()
On July 16, 2021, The Hillfeatured an Op-Ed by AFAR grantee Matt Kaeberlein, PhD, explaining the importance of funding geroscience today. Dr. Kaeberlein explores how both public and private investment in the field can produce increases in lifespan and healthspan for us all while also generating long-term economic gains and high returns for funders.
Dr. Kaeberlein is a 2006 Glenn Foundation for Medical Research and AFAR Grants for Junior Faculty recipient, and a 2007 Glenn Foundation for Medical Research Breakthroughs in Gerontology (BIG) Award recipient. He is also the Co-Director at the University of Washington Nathan Shock Center of Excellence in the Basic Biology of Aging, the Director of the Healthy Aging and Longevity Research Institute, the President of the American Aging Association, the Co-Director of the Dog Aging Project, and a Professor at the University of Washington.
Read the Op-Ed, “Scientists are demystifying aging – funding could add decades to our lives,” here.
The piece was also featured in MSN here.
Learnhow your donation to AFAR can help fund grants for early-to-mid-career investigators working to uncover major breakthroughs in aging research. Help us build the pipeline for discoveries and therapeutics that can help us all live healthier for longer today. Donate to AFAR here.